← Back
$SLDB All transactions

Solid Biosciences Inc.

▼ SELL

$ Value

$25K

Shares

4,932

Price

$5

Filed

Dec 4

Insider

Name

Howton David T

Title

Chief Operating Officer

CIK

0001529297

Roles

Officer

Transaction Details

Transaction Date

2025-12-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,908

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). | This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton. | The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Filing Info

Accession No.

0001193125-25-308118

Form Type

4

Issuer CIK

0001707502

Howton David T's History

Date Ticker Type Value
2026-01-29 SLDB A $0
2025-12-03 SLDB $25K
2025-12-02 SLDB M
2025-12-02 SLDB M $0
2025-08-14 SLDB A $0
2025-08-14 SLDB A $0

Other Insiders at SLDB (90d)

Insider Bought Sold Last
SMITH IAN F 2026-04-02
Howton David T
Chief Operating Officer
2026-01-29
Cumbo Alexander
President and CEO
2026-01-29
Tan Kevin
CFO & Treasurer
2026-01-29
Hanrahan Jessie
Chief Regulatory Officer
2026-01-29
Herzich Paul
Chief Technology Officer
2026-01-29
Brooks Gabriel
Chief Medical Officer
2026-01-29